Development and Validation of Pomalidomide Determination in Human Plasma by HPLC-MS/MS Method

Introduction. B-cell malignancies of the plasma cell leads to the second most spread hematological malignancy disease, called multiple myeloma. Pomalidomide is used in case of previous multiple myeloma ineffective treatment. Pomalidomide is a thalidomide synthetic derived, approved as immunomodulato...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: T. N. Komarov, I. E. Shohin, M. A. Tokareva, O. A. Archakova, D. S. Bogdanova, A. A. Aleshina, N. S. Bagaeva, V. V. Davydanova, N. P. Sadchikova
Formato: Artigo
Idioma:Russo
Publicado em: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-11-01
Colecção:Разработка и регистрация лекарственных средств
Assuntos:
pomalidomide
plasma
hplc-ms/ms
validation
bioequivalence
Acesso em linha:https://www.pharmjournal.ru/jour/article/view/864
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados